CWG
CARM

C WorldWide Group’s Carisma Therapeutics CARM Stock Holding History

C WorldWide Group’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,372
Closed -$1.49M – 129
2015
Q1 		$1.49M Buy
8,372
+5,000
+148% +$1.09M 0.02% 92
2014
Q4 		$801K Sell
3,372
-1,628
-33% -$365K 0.01% 89
2014
Q3 		$1.16M Buy
+5,000
New +$1.19M 0.02% 90

Other funds holding CARM

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

C WorldWide Group's CARM Position: Q2 2015 in Review

C WorldWide Group sold out of Carisma Therapeutics (CARM) in Q2 2015, closing a stake of 8,372 shares — an estimated $1.49M sold.

C WorldWide Group first reported a position in CARM in Q3 2014 and held it in 3 quarters. The position peaked at $1.49M in Q1 2015. 41 funds tracked by Wall St. Rank hold CARM as of Q2 2015.

  • C WorldWide Group reported no remaining Carisma Therapeutics position as of Q2 2015 after selling out during the quarter.
  • C WorldWide Group sold 8,372 Carisma Therapeutics shares in Q2 2015, an estimated $1.49M.
  • C WorldWide Group first reported a position in Carisma Therapeutics in Q3 2014 and held it in 3 quarters.
  • C WorldWide Group's Carisma Therapeutics position peaked at $1.49M in Q1 2015.
  • 41 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q2 2015.

Based on C WorldWide Group's 13F filing for Q2 2015, filed 21 Jul 2015.